世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

モンテルカスト・ナトリウムチュアブル錠の世界市場成長 2023-2029


Global Montelukast Sodium Chewable Tablets Market Growth 2023-2029

Montelukast Sodium Chewable Tabletsの世界市場規模は、2022年の100万米ドルから2029年には100万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率は%であると予測されています。 Montelu... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2023年6月23日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		119 英語

　

サマリー

Montelukast Sodium Chewable Tabletsの世界市場規模は、2022年の100万米ドルから2029年には100万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率は%であると予測されています。
Montelukast Sodium Chewable Tabletsの米国市場は、2023年から2029年にかけて年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。
モンテルカスト・ナトリウムチュアブル錠の中国市場は、2023年から2029年までの年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定される。
モンテルカスト・ナトリウムチュアブル錠のヨーロッパ市場は、2023年から2029年までの年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定される。
世界の主要なMontelukast Sodium Chewable Tabletsプレーヤーは、Organon、Merck、Teva Pharmaceuticals、Sandoz、Mylan N.V.、GSK、Pfizer、Yangtze River Pharmaceutical (Group) Co.Ltd.、Beijing Foyou Pharma CO.Ltd.などをカバーしています。売上高では、2022年に世界の大手2社がほぼ％のシェアを占めている。
モンテルカスト・ナトリウム・チュアブル錠は選択的システイニルロイコトリエン受容体拮抗薬で、主に喘息の予防と長期治療、アレルギー性鼻炎の症状緩和に使用され、慢性蕁麻疹や閉塞性睡眠時無呼吸症候群などの非重症疾患の小児にも使用できる。
LPI（エルピーアイ情報）の最新調査レポート「モンテルカスト・ナトリウムチュアブル錠の産業予測」は、過去の売上高を調べ、2022年のモンテルカスト・ナトリウムチュアブル錠の世界総売上高をレビューし、2023年から2029年までのモンテルカスト・ナトリウムチュアブル錠の予測売上高を地域別・市場分野別に包括的に分析しています。本レポートでは、Montelukast Sodium Chewable Tabletsの売上高を地域別、市場分野別、サブセクター別に分類し、世界のMontelukast Sodium Chewable Tablets産業の詳細な分析を百万米ドル単位で提供しています。
このインサイトレポートでは、世界のMontelukast Sodium Chewable Tabletsの状況を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにしています。また本レポートでは、Montelukast Sodium Chewable Tabletsのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡を中心に、世界の主要企業の戦略を分析し、加速する世界のMontelukast Sodium Chewable Tablets市場におけるこれらの企業の独自の地位をより深く理解しています。
この調査レポートは、Montelukast Sodium Chewable Tabletsの世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界のMontelukast Sodium Chewable Tabletsの現状と将来の軌道について非常にニュアンスのある見解を提供します。
当レポートでは、モンテルカスト・ナトリウムチュアブル錠市場の製品タイプ別、用途別、主要メーカー別、主要地域別および国別の包括的な概要、市場シェア、成長機会を紹介しています。
市場の細分化
タイプ別セグメント
4mg/錠剤
5mg/錠剤
用途別セグメント
病院
クリニック
小売薬局
その他
本レポートは地域別にも市場を分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
オルガノン
メルク
テバ・ファーマシューティカルズ
サンド
マイランN.V.
GSK
ファイザー
長江薬業（集団）有限公司
北京豊友医薬有限公司
南京日新医薬有限公司
浙江諾徳薬業有限公司
合肥英泰医薬有限公司
魯南ベター製薬有限公司
四川大塚製薬有限公司
斉魯薬業（海南）有限公司
Cspc欧夷医薬有限公司
本レポートで扱う主な質問
世界のMontelukast Sodiumチュアブル錠市場の10年見通しは？
世界および地域別のMontelukast Sodiumチュアブル錠市場成長の要因は何か？
市場別・地域別で最も急成長する技術は何か？
モンテルカスト・ナトリウムチュアブル錠の市場機会は最終市場規模によってどのように異なるのか？
モンテルカスト・ナトリウムチュアブル錠のタイプ別、用途別内訳は？
COVID-19とロシア・ウクライナ戦争の影響は？


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast Sodium Chewable Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast Sodium Chewable Tablets by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Sodium Chewable Tablets Segment by Type
2.2.1 4mg/tablet
2.2.2 5mg/tablet
2.3 Montelukast Sodium Chewable Tablets Sales by Type
2.3.1 Global Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Sodium Chewable Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sodium Chewable Tablets Sale Price by Type (2018-2023)
2.4 Montelukast Sodium Chewable Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Montelukast Sodium Chewable Tablets Sales by Application
2.5.1 Global Montelukast Sodium Chewable Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Sodium Chewable Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sodium Chewable Tablets Sale Price by Application (2018-2023)
3 Global Montelukast Sodium Chewable Tablets by Company
3.1 Global Montelukast Sodium Chewable Tablets Breakdown Data by Company
3.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sodium Chewable Tablets Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Sodium Chewable Tablets Revenue by Company (2018-2023)
3.2.2 Global Montelukast Sodium Chewable Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sodium Chewable Tablets Sale Price by Company
3.4 Key Manufacturers Montelukast Sodium Chewable Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Sodium Chewable Tablets Product Location Distribution
3.4.2 Players Montelukast Sodium Chewable Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast Sodium Chewable Tablets by Geographic Region
4.1 World Historic Montelukast Sodium Chewable Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Sodium Chewable Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sodium Chewable Tablets Sales Growth
4.4 APAC Montelukast Sodium Chewable Tablets Sales Growth
4.5 Europe Montelukast Sodium Chewable Tablets Sales Growth
4.6 Middle East & Africa Montelukast Sodium Chewable Tablets Sales Growth
5 Americas
5.1 Americas Montelukast Sodium Chewable Tablets Sales by Country
5.1.1 Americas Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
5.1.2 Americas Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
5.2 Americas Montelukast Sodium Chewable Tablets Sales by Type
5.3 Americas Montelukast Sodium Chewable Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sodium Chewable Tablets Sales by Region
6.1.1 APAC Montelukast Sodium Chewable Tablets Sales by Region (2018-2023)
6.1.2 APAC Montelukast Sodium Chewable Tablets Revenue by Region (2018-2023)
6.2 APAC Montelukast Sodium Chewable Tablets Sales by Type
6.3 APAC Montelukast Sodium Chewable Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Sodium Chewable Tablets by Country
7.1.1 Europe Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
7.1.2 Europe Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
7.2 Europe Montelukast Sodium Chewable Tablets Sales by Type
7.3 Europe Montelukast Sodium Chewable Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Sodium Chewable Tablets by Country
8.1.1 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Type
8.3 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Sodium Chewable Tablets
10.3 Manufacturing Process Analysis of Montelukast Sodium Chewable Tablets
10.4 Industry Chain Structure of Montelukast Sodium Chewable Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Sodium Chewable Tablets Distributors
11.3 Montelukast Sodium Chewable Tablets Customer
12 World Forecast Review for Montelukast Sodium Chewable Tablets by Geographic Region
12.1 Global Montelukast Sodium Chewable Tablets Market Size Forecast by Region
12.1.1 Global Montelukast Sodium Chewable Tablets Forecast by Region (2024-2029)
12.1.2 Global Montelukast Sodium Chewable Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Sodium Chewable Tablets Forecast by Type
12.7 Global Montelukast Sodium Chewable Tablets Forecast by Application
13 Key Players Analysis
13.1 Organon
13.1.1 Organon Company Information
13.1.2 Organon Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.1.3 Organon Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Organon Main Business Overview
13.1.5 Organon Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.2.3 Merck Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Information
13.3.2 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.3.3 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceuticals Main Business Overview
13.3.5 Teva Pharmaceuticals Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.4.3 Sandoz Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.5.3 Mylan N.V. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.6.3 GSK Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.7.3 Pfizer Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.9 Beijing Foyou Pharma CO.,Ltd.
13.9.1 Beijing Foyou Pharma CO.,Ltd. Company Information
13.9.2 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.9.3 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Foyou Pharma CO.,Ltd. Main Business Overview
13.9.5 Beijing Foyou Pharma CO.,Ltd. Latest Developments
13.10 Nanjing Hicin Pharmaceutical Co., Ltd.
13.10.1 Nanjing Hicin Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.10.3 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Hicin Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Hicin Pharmaceutical Co., Ltd. Latest Developments
13.11 Zhejiang Nuode Pharmaceutical Co., Ltd.
13.11.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Company Information
13.11.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.11.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Latest Developments
13.12 Hefei Yingtai Pharmaceutical Co., Ltd.
13.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Sichuan Otsuka Pharmaceutical Co., Ltd.
13.14.1 Sichuan Otsuka Pharmaceutical Co., Ltd. Company Information
13.14.2 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.14.3 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sichuan Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Sichuan Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.15 Qilu Pharmaceutical (Hainan) Co., Ltd.
13.15.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information
13.15.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.15.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business Overview
13.15.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
13.16 Cspc Ouyi Pharmaceutical Co., Ltd.
13.16.1 Cspc Ouyi Pharmaceutical Co., Ltd. Company Information
13.16.2 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.16.3 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cspc Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

The global Montelukast Sodium Chewable Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Montelukast Sodium Chewable Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Montelukast Sodium Chewable Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Montelukast Sodium Chewable Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Montelukast Sodium Chewable Tablets players cover Organon, Merck, Teva Pharmaceuticals, Sandoz, Mylan N.V., GSK, Pfizer, Yangtze River Pharmaceutical (Group) Co., Ltd. and Beijing Foyou Pharma CO.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Montelukast Sodium Chewable Tablets is a selective cysteinyl leukotriene receptor antagonist, mainly used for the prevention and long-term treatment of asthma and to relieve the symptoms of allergic rhinitis, and can also be used for chronic urticaria and children with non-severe diseases such as obstructive sleep apnea.
LPI (LP Information)' newest research report, the “Montelukast Sodium Chewable Tablets Industry Forecast” looks at past sales and reviews total world Montelukast Sodium Chewable Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium Chewable Tablets sales for 2023 through 2029. With Montelukast Sodium Chewable Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium Chewable Tablets industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium Chewable Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Chewable Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Montelukast Sodium Chewable Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium Chewable Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium Chewable Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium Chewable Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
4mg/tablet
5mg/tablet
Segmentation by application
Hospital
Clinic
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Organon
Merck
Teva Pharmaceuticals
Sandoz
Mylan N.V.
GSK
Pfizer
Yangtze River Pharmaceutical (Group) Co., Ltd.
Beijing Foyou Pharma CO.,Ltd.
Nanjing Hicin Pharmaceutical Co., Ltd.
Zhejiang Nuode Pharmaceutical Co., Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Lunan Better Pharmaceutical Co., Ltd.
Sichuan Otsuka Pharmaceutical Co., Ltd.
Qilu Pharmaceutical (Hainan) Co., Ltd.
Cspc Ouyi Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium Chewable Tablets market?
What factors are driving Montelukast Sodium Chewable Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium Chewable Tablets market opportunities vary by end market size?
How does Montelukast Sodium Chewable Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Montelukast Sodium Chewable Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Montelukast Sodium Chewable Tablets by Country/Region, 2018, 2022 & 2029
2.2 Montelukast Sodium Chewable Tablets Segment by Type
2.2.1 4mg/tablet
2.2.2 5mg/tablet
2.3 Montelukast Sodium Chewable Tablets Sales by Type
2.3.1 Global Montelukast Sodium Chewable Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Montelukast Sodium Chewable Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Montelukast Sodium Chewable Tablets Sale Price by Type (2018-2023)
2.4 Montelukast Sodium Chewable Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Montelukast Sodium Chewable Tablets Sales by Application
2.5.1 Global Montelukast Sodium Chewable Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Montelukast Sodium Chewable Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Montelukast Sodium Chewable Tablets Sale Price by Application (2018-2023)
3 Global Montelukast Sodium Chewable Tablets by Company
3.1 Global Montelukast Sodium Chewable Tablets Breakdown Data by Company
3.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Montelukast Sodium Chewable Tablets Sales Market Share by Company (2018-2023)
3.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Montelukast Sodium Chewable Tablets Revenue by Company (2018-2023)
3.2.2 Global Montelukast Sodium Chewable Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Montelukast Sodium Chewable Tablets Sale Price by Company
3.4 Key Manufacturers Montelukast Sodium Chewable Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Sodium Chewable Tablets Product Location Distribution
3.4.2 Players Montelukast Sodium Chewable Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast Sodium Chewable Tablets by Geographic Region
4.1 World Historic Montelukast Sodium Chewable Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Montelukast Sodium Chewable Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Montelukast Sodium Chewable Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Montelukast Sodium Chewable Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Montelukast Sodium Chewable Tablets Sales Growth
4.4 APAC Montelukast Sodium Chewable Tablets Sales Growth
4.5 Europe Montelukast Sodium Chewable Tablets Sales Growth
4.6 Middle East & Africa Montelukast Sodium Chewable Tablets Sales Growth
5 Americas
5.1 Americas Montelukast Sodium Chewable Tablets Sales by Country
5.1.1 Americas Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
5.1.2 Americas Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
5.2 Americas Montelukast Sodium Chewable Tablets Sales by Type
5.3 Americas Montelukast Sodium Chewable Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Sodium Chewable Tablets Sales by Region
6.1.1 APAC Montelukast Sodium Chewable Tablets Sales by Region (2018-2023)
6.1.2 APAC Montelukast Sodium Chewable Tablets Revenue by Region (2018-2023)
6.2 APAC Montelukast Sodium Chewable Tablets Sales by Type
6.3 APAC Montelukast Sodium Chewable Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Sodium Chewable Tablets by Country
7.1.1 Europe Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
7.1.2 Europe Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
7.2 Europe Montelukast Sodium Chewable Tablets Sales by Type
7.3 Europe Montelukast Sodium Chewable Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Sodium Chewable Tablets by Country
8.1.1 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Montelukast Sodium Chewable Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Type
8.3 Middle East & Africa Montelukast Sodium Chewable Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Sodium Chewable Tablets
10.3 Manufacturing Process Analysis of Montelukast Sodium Chewable Tablets
10.4 Industry Chain Structure of Montelukast Sodium Chewable Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Sodium Chewable Tablets Distributors
11.3 Montelukast Sodium Chewable Tablets Customer
12 World Forecast Review for Montelukast Sodium Chewable Tablets by Geographic Region
12.1 Global Montelukast Sodium Chewable Tablets Market Size Forecast by Region
12.1.1 Global Montelukast Sodium Chewable Tablets Forecast by Region (2024-2029)
12.1.2 Global Montelukast Sodium Chewable Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Sodium Chewable Tablets Forecast by Type
12.7 Global Montelukast Sodium Chewable Tablets Forecast by Application
13 Key Players Analysis
13.1 Organon
13.1.1 Organon Company Information
13.1.2 Organon Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.1.3 Organon Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Organon Main Business Overview
13.1.5 Organon Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.2.3 Merck Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Teva Pharmaceuticals
13.3.1 Teva Pharmaceuticals Company Information
13.3.2 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.3.3 Teva Pharmaceuticals Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Pharmaceuticals Main Business Overview
13.3.5 Teva Pharmaceuticals Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.4.3 Sandoz Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.5.3 Mylan N.V. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 GSK
13.6.1 GSK Company Information
13.6.2 GSK Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.6.3 GSK Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GSK Main Business Overview
13.6.5 GSK Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.7.3 Pfizer Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.8.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.8.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.8.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.8.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.9 Beijing Foyou Pharma CO.,Ltd.
13.9.1 Beijing Foyou Pharma CO.,Ltd. Company Information
13.9.2 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.9.3 Beijing Foyou Pharma CO.,Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Foyou Pharma CO.,Ltd. Main Business Overview
13.9.5 Beijing Foyou Pharma CO.,Ltd. Latest Developments
13.10 Nanjing Hicin Pharmaceutical Co., Ltd.
13.10.1 Nanjing Hicin Pharmaceutical Co., Ltd. Company Information
13.10.2 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.10.3 Nanjing Hicin Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Hicin Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Nanjing Hicin Pharmaceutical Co., Ltd. Latest Developments
13.11 Zhejiang Nuode Pharmaceutical Co., Ltd.
13.11.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Company Information
13.11.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.11.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Latest Developments
13.12 Hefei Yingtai Pharmaceutical Co., Ltd.
13.12.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.12.2 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.12.3 Hefei Yingtai Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.13 Lunan Better Pharmaceutical Co., Ltd.
13.13.1 Lunan Better Pharmaceutical Co., Ltd. Company Information
13.13.2 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.13.3 Lunan Better Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lunan Better Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Lunan Better Pharmaceutical Co., Ltd. Latest Developments
13.14 Sichuan Otsuka Pharmaceutical Co., Ltd.
13.14.1 Sichuan Otsuka Pharmaceutical Co., Ltd. Company Information
13.14.2 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.14.3 Sichuan Otsuka Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Sichuan Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Sichuan Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.15 Qilu Pharmaceutical (Hainan) Co., Ltd.
13.15.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information
13.15.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.15.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Main Business Overview
13.15.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Latest Developments
13.16 Cspc Ouyi Pharmaceutical Co., Ltd.
13.16.1 Cspc Ouyi Pharmaceutical Co., Ltd. Company Information
13.16.2 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Product Portfolios and Specifications
13.16.3 Cspc Ouyi Pharmaceutical Co., Ltd. Montelukast Sodium Chewable Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Cspc Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医薬）の最新刊レポート

LP Information社の医薬品・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（sodium）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/19　10:26

155.94 円

162.31 円

199.02 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.